For the year ending 2025-12-31, TDOC made $2,529,977K in revenue. -$196,662K in net income. Net profit margin of -7.77%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 2,529,977 | 2,569,574 | ||
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 771,593 | 751,270 | ||
| Advertising and marketing | 653,372 | 705,787 | ||
| Sales | 194,518 | 204,993 | ||
| Technology and development | 277,922 | 307,274 | ||
| General and administrative | 431,891 | 435,490 | ||
| Goodwill impairments | 71,763 | 790,000 | ||
| Acquisition, integration, and transformation costs | 9,010 | 1,743 | ||
| Restructuring costs | 18,785 | 20,355 | ||
| Amortization of intangible assets | 350,764 | 363,365 | ||
| Depreciation of property and equipment | 13,314 | 10,183 | ||
| Total costs and expenses | 2,792,932 | 3,590,460 | ||
| Loss from operations | -262,955 | -1,020,886 | ||
| Interest income | 36,770 | 57,071 | ||
| Interest expense | 19,714 | 23,803 | ||
| Other expense (income), net | 10,369 | -6,035 | ||
| Loss before provision for income taxes | -235,530 | -993,653 | ||
| Provision for income taxes | -35,208 | 7,592 | ||
| Net loss | -200,322 | -1,001,245 | ||
| Currency translation adjustment | 3,660 | -1,398 | ||
| Comprehensive loss | -196,662 | -1,002,643 | ||
| Basic EPS | -1.14 | -5.87 | ||
| Diluted EPS | -1.14 | -5.87 | ||
| Basic Average Shares | 176,221,530 | 170,564,088 | ||
| Diluted Average Shares | 176,221,530 | 170,564,088 | ||
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)